| Application no. and date | 19768898.9 (espacenet) (Federated) (European Patent Register), 20190719 | | Patent/reg. no. and date | DK/EP 3823623, 20241009 | | Publication date | 20210526 | | Priority no. and date | US 201862700977 P, 20180720, US 201862730184 P, 20180912, US 201962839273 P, 20190426 | | EP pub. no. and date |
EP 3823623 20210526 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P85722DK01 | | Inventor | DYROFF, Martin, 18 Green Way
Wayland, MA 01778, US,
MITCHELL, David, 15835 Diamond Point
Broomfield, CO 80023, US,
PAPASOULIOTIS, Orestis, 82 route de Frontenex
1208 Geneva, CH | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 25/28 (2006.01) | | Title | SUBSTITUERET AMINO-PYRIMIDINFORBINDELSE TIL ANVENDELSE I EN FREMGANGSMÅDE TIL BEHANDLING OG FOREBYGGELSE AF MULTIPEL SKLEROSE | | Int. application no. | IB2019056198 | | Int. publication no. | WO2020016850 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
